Where to buy ipamorelin.

You can buy ipamorelin from research-supply vendors online, and nowhere else. It isn't an approved drug, and the FDA closed the compounding-pharmacy door in 2023. Where to buy ipamorelin therefore comes down to which vendor, and this guide covers the chemistry trap that makes cheap ipamorelin not really ipamorelin.

Ipamorelin

Referenced in this guide

Batch-matched COAHPLC + mass specResearch use only

The Ipamorelin referenced throughout this article, supplied as a research compound with a certificate of analysis matched to the lot you receive — the check this site argues you should hold any supplier to.

Shop Ipamorelin

Where can you buy ipamorelin?

Ipamorelin comes from research-supply vendors online, and that is the only channel left open. It sits in a regulatory dead zone: not scheduled, not approved, and no longer compounding-eligible. Three channels have been used historically:

• Prescription: Not available. No FDA approval means no physician can write a prescription for ipamorelin.
• Compounding pharmacy: Closed since 2023. The FDA added ipamorelin to the 503A ineligibility list. The 503A channel permits pharmacists to compound custom medications for individual patients; ipamorelin is no longer eligible.
• Research-supply vendor: The current legal channel. Vendors sell ipamorelin as a reference compound for laboratory use, labeled Research Use Only under 21 CFR § 809.10(b)(9).

So the research-supply channel is what the rest of this guide is about. We treat it as the only lawful route to ipamorelin in a laboratory context.

Six vendors, all checked on 13 August 2026 against what each will show you before you pay: a third-party certificate you can open, and whether the testing lab is named in the vendor's own copy or only inside the PDF. We did not verify ipamorelin prices, so there is no price column here — pricing across these same vendors is benchmarked on BPC-157 in our full vendor comparison, where the spread runs $6.30–$12.45 per mg. Stock varies by compound, so check each catalogue for ipamorelin.

Three caveats travel with that table. Peptriva and Red Rock sell 10 mg vials only, so their per-milligram figures in the BPC-157 benchmark are not comparable with a 5 mg row. Swiss Chems sells its BPC-157 as the arginine salt rather than the plain peptide, so it is not a like-for-like product. And Red Rock publishes no certificate of analysis at all, despite advertising verified COAs. Where To Buy Peptides earns a commission on purchases made through its links, Peptriva included — see our disclosure.

The identity check specific to ipamorelin: CAS 170851-70-4 on the identity line. Our verified set holds no observed mass for it, so ask for the full sequence written out instead — two of ipamorelin's residues are non-standard, and nothing on a vial label shows whether they are there.

What is ipamorelin, exactly?

Ipamorelin is a five-amino-acid peptide. The sequence reads Aib-His-D-2-Nal-D-Phe-Lys-NH₂. Five residues sounds simple. Only one of them is normal.

Here's the chemistry that matters. Aib is α-aminoisobutyric acid, an unnatural amino acid found in no standard protein. D-2-Nal is D-2-naphthylalanine, another unnatural one with a bulky side chain.

Three of the five residues are mirror-image "D" versions of natural amino acids: D-2-Nal, D-Phe and D-Lys. These aren't decoration. They're the reason ipamorelin behaves differently from older peptides like GHRP-6.

Ipamorelin activates the ghrelin receptor, GHS-R1a, on pituitary cells. That triggers growth hormone release. So do GHRP-2 and GHRP-6. The difference is selectivity.

Studies report that ipamorelin stimulates GH release with minimal cortisol, prolactin or appetite spillover. GHRP-6 reliably elevates cortisol and prolactin and stimulates appetite. The Aib and D-2-Nal residues are understood to underlie that cleaner profile, per Rahman and colleagues.

What should you check before buying ipamorelin?

Check ipamorelin for four things. Aib named on the CoA. D-amino acid stereochemistry confirmed. A price that reflects those unnatural residues, and freeze-dried vials rather than pre-mixed kits. The standard eight vendor criteria apply on top.

Three of the four are variations on one theme. Ipamorelin's selling point is selectivity, and selectivity depends on chemistry only the CoA can verify.

1. Aib confirmed on the CoA

The Aib residue at position 1 is structurally specific to ipamorelin, and it isn't a natural amino acid. A CoA listing only "5-amino-acid pentapeptide" without naming Aib is incomplete.

Check the math. A peptide with alanine swapped for Aib would weigh 14 Da lighter, and the [M+H]⁺ mass-spec peak would land at roughly 698.4 instead of 712.4. The identity report should show the full sequence with Aib notation, and the mass-spec trace should match 711.9 g/mol within about 0.5 Da.

2. D-amino acid stereochemistry confirmed

Three residues are D-isomers, not the natural L-form. A peptide made with the wrong stereochemistry would weigh exactly the same. Mass-spec alone can’t catch it.

A compliant CoA should show explicit D-/L- notation in the chemical name, plus either chiral HPLC or amino-acid analysis after hydrolysis. Without stereochemistry verification, a pentapeptide may confirm the correct mass but not confirm ipamorelin’s identity.

3. Pricing that reflects the unnatural amino acids

The pharmacological value of ipamorelin versus older GHRPs lies in its selectivity profile. GHRP-6 costs less to synthesize because it uses only standard amino acids. Ipamorelin priced at GHRP-6 levels warrants scrutiny of the synthesis economics.

The unnatural amino acid building blocks cost meaningfully more than standard L-amino acids. Below-floor pricing can indicate skipped purification or residue substitution. That gives you a pentapeptide matching the label by name while diverging from the real structure at the receptor.

4. Lyophilized vials, not pre-mixed kits

Freeze-dried powder is the standard delivery form for third-party tested research peptides, ipamorelin included. Reconstitution happens in the laboratory, right before the assay.

Some vendors sell pre-mixed CJC-1295 and ipamorelin liquid kits. Liquid is less stable than powder. More importantly, a single blend CoA doesn't confirm either peptide individually. We'd want separate freeze-dried vials with their own CoAs.

What does ipamorelin cost in 2026?

Ipamorelin costs $50–$100 for a 5 mg vial and $80–$150 for 10 mg. It sits in a strange pricing zone. At five residues it should be cheap. With two unnatural amino acids and three D-isomers, it costs meaningfully more per mg than a standard 5-mer. The 2026 retail map:

• 5 mg vial: $50–$100, or $10–$20/mg. The most common size.
• 10 mg vial: $80–$150, or $8–$15/mg. Better per-mg value.
• CJC-1295 + ipamorelin bundle: $90–$150. Stack discount. Verify both individual CoAs ship.
• Multi-vial discounts: 10–25% off for 3-pack or 6-pack purchases.

Below $40 per 5 mg vial, the synthesis economics warrant scrutiny. The unnatural amino acid building blocks are not cheap; material priced below that floor may reflect shortcut purification or residue substitution. Above $30 per mg, pricing reflects retail markup rather than additional synthesis quality.

Why is ipamorelin sold alongside CJC-1295?

Ipamorelin is frequently co-sourced with CJC-1295 because the two hit complementary receptor systems on pituitary cells. Preclinical models have studied them together for exactly that reason.

Ipamorelin is a ghrelin-receptor agonist, acting at GHS-R1a. CJC-1295 is a GHRH-receptor agonist. Both converge on growth hormone release through different intracellular pathways.

Preclinical models report that combining the two produces a larger and more pulsatile GH response than either alone. A 2026 sports-medicine review by Mayfield and colleagues noted improved muscle tension in mice. Controlled human trial data for the pairing is absent.

If you buy both, we'd source them from the same vendor. Matching lot dates makes the identity-verification workflow simpler. See CJC-1295 vs ipamorelin and the stack research article.

Is ipamorelin legal to buy?

Yes. Ipamorelin is legal to buy as a research reference compound, and illegal to sell for human use. It isn't FDA-approved for anything. Its biggest human trial was a Phase III study for postoperative ileus, which failed, and Helsinn Therapeutics dropped development.

Zero randomized human trials have tested ipamorelin for muscle mass, adipose-tissue reduction or tissue-repair endpoints, per Mendias and Awan.

The 2023 FDA action put ipamorelin on the 503A ineligibility list, closing the compounding-pharmacy door. Research sales operate under Research Use Only labeling at 21 CFR § 809.10(b)(9). See peptides and the 2023 503A categorization.

Ipamorelin is also banned by WADA under category S2. Anti-doping labs have validated mass-spec detection. Any athlete subject to WADA testing should assume it’s detectable. See the 2026 WADA peptide list.

What are the red flags when buying ipamorelin?

The ipamorelin red flag we weigh heaviest is a CoA that never names Aib, because that residue is what makes the molecule selective. More we would walk away from:

• CoA missing Aib or D-amino acid notation. The sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂ must appear explicitly. “5-amino-acid pentapeptide” without residue identity is incomplete.
• Mass-spec not matching 712.4 [M+H]⁺. Alanine instead of Aib = 14 Da lighter. Wrong mass means wrong molecule.
• Pricing at GHRP-6 levels. GHRP-6 uses only standard amino acids and synthesizes cheap. Ipamorelin at the same price is either subsidized or substituted.
• Pre-mixed CJC + ipamorelin kits without separate CoAs. A blend CoA doesn’t prove each peptide’s identity. Demand both individual reports.
• “Modified” or “Enhanced” ipamorelin variants. The standard pentapeptide is the molecule with the published pharmacology. Branded variants are marketing.
• Clinical claims on the product page. “Builds lean muscle.” “Reverses aging.” That’s an unapproved drug claim, and the FDA acts on these.
• Missing CAS number. CAS 170851-70-4 is the unique chemical identifier. Its absence is a red flag.
• No third-party ISO 17025 lab verification. Internal QC isn’t enough. Stereochemistry verification needs a real outside lab.

Ipamorelin

5 mg ≥99% pure Lyophilized

Selective GHS-R1a agonist, sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, CAS 170851-70-4. The same reference compound used across the cited preclinical studies. COA with HPLC trace, mass-spec at [M+H]⁺ 712.4, and explicit Aib + D-amino acid identity ships with every order.

Learn more

Frequently asked questions

Is ipamorelin legal to acquire for research?

Ipamorelin is legal to acquire as a research reference compound from vendors that supply it under Research Use Only labeling. It is not available by prescription and is not compounding-eligible under 21 CFR § 503A. Selling ipamorelin for human consumption is illegal; acquiring it as labeled research material from a compliant vendor is lawful.

How much does ipamorelin cost?

Ipamorelin runs $50–$100 per 5 mg vial or $80–$150 per 10 mg vial in 2026, with CJC-1295 kits at $90–$150 per pair. Below those benchmarks, the synthesis economics suggest skipped purification or substituted amino acids. The unnatural building blocks aren't cheap to source or incorporate.

Why is ipamorelin co-investigated with CJC-1295?

Ipamorelin (GHS-R1a agonist) and CJC-1295 (GHRH-receptor agonist) activate complementary receptor pathways on the same pituitary cells. Preclinical models have shown that the combination produces a larger and more pulsatile GH response than either compound alone. Controlled human trial evidence for the pairing is absent. See CJC-1295 vs ipamorelin.

How is ipamorelin different from GHRP-2 and GHRP-6?

All three are GHS-R1a agonists with comparable GH-stimulating potency in preclinical assays. The pharmacological distinction is selectivity. Studies have reported that ipamorelin produces minimal cortisol, prolactin, and appetite off-target effects at GH-stimulating concentrations. GHRP-6 has been shown to elevate cortisol and prolactin reliably and to stimulate appetite via direct ghrelin-mimetic activity. GHRP-2 sits between the two in selectivity profile.

What should an ipamorelin Certificate of Analysis show?

An ipamorelin CoA should spell out the full sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂, plus CAS 170851-70-4, HPLC purity ≥98% with a chromatogram, and mass-spec at [M+H]⁺ 712.4.

Then water content 2–8% by Karl Fischer titration, a chemistry test for trace water, and an ISO 17025-accredited lab named on the report. For ipamorelin specifically, also look for chiral HPLC or amino-acid analysis confirming the D-amino acids. See reading a CoA.

Is ipamorelin banned by WADA?

Yes. Category S2, banned in and out of competition. Detection methods are validated and in active use. If you’re tested, assume it’ll show up. See the 2026 WADA peptide list.